Matches in Nanopublications for { ?s ?p "DDI between Lovastatin and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may increase the effect and toxicity of lovastatin by decreasing its metabolism. Concomitant therapy is contraindicated. [drugbank_resource:DB00227_DB01319]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.